Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 11, 462 (2005)
doi:10.1038/nm0505-462a
Personalized medicine prompts push to redesign clinical trials
Emily Singer1
- Boston
Drug trials should aim to identify subgroups who respond.Three prominent cancer organizations are on a quest to redesign clinical trials, saying that additional testing before and during trials will highlight individual differences in drug response and detect successful targeted therapies faster.
To read this story in full you will need to login or make a payment (see right).
